Institute researchers are involved in a number of clinical trials that show promise for the translation of stem cell research from bench to bedside.
Below is a list of the current clinical trials underway from the researchers at CSCI.
If you would like to find out more about clinical trials, please contact us at enquiries@stemcells.cam.ac.uk
|
Trial Lead |
Topic | Description | More details |
|
Parkinson's disease |
A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease (STEM-PD) |
NCT05635409 | |
|
Parkinson's disease |
TRANSEURO open label transplant study in Parkinson's Disease. | NCT01898390 | |
|
Blood components |
RESTORE - recovery and survival of stem cell originated red cells - currently pending approval from the Health Research Authority. | RESTORE | |
| Osteoarthritis | Evaluation the efficacy of adipose derived mesenchymal stromal cells in patients with knee osteoarthritis. | NCT02838069 | |
| Myeloproliferative neoplasms | Redeployment of tamoxifen to modulate the bone marrow niche and treat myeloproliferative neoplasms | 2015-05497-38 | |
| Dr Daniel Hodson | High-grade B-cell Lymphoma | DLBCL Interim Response Evaluation for Customised Therapy (DIRECT) | NCT04226937 |
| Professor Brian Huntly | Chronic Myelogenous Leukemia | Asciminib Treatment Optimization in ≥ 3rd Line CML-CP. | NCT04948333 |
| Prof Roger Barker | Huntington’s disease | A trial to look at how different doses of felodipine are tolerated in people with early-stage Huntington’s disease | ISRCTN56240656 |
| Dr Konstantinos Tzelepis | Advanced Cancer | Oral Administration of STC-15 in Subjects With Advanced Malignancies | NCT05584111 |